At the conference, Markus Bauss, Managing Director of SHL Connect, will provide a presentation on the topic of “Connectivity in Drug Delivery & Smart Administration.”
Menu
SHL is going to speak about the requirements on prefillable containers for the perfect fit into devices.
Both Molly® 2.25 and Molly® C will be available for demonstration at the SHL booth in the upcoming Pharmapack event.
With the rapid growth of SHL Group and along with new innovations and technologies developed for pen and autoinjectors, the Taoyuan facility requires expansion of space and thus will be relocating to a new site in Nankan, Taoyuan.
On December 15 and 16, SHL held a donation event for new or second-hand items to be donated to indigenous children of remote areas on the Eastern coast of Taiwan, namely in Taitung and Hualien.
Within just two years of reaching a milestone of 2,500 employees, SHL Group has rapidly reached 3,000 employees worldwide.
With strong in-house design services that offer innovative designs for medical devices such as autoinjectors, pen injectors, and inhalers, SHL has successfully introduced numerous next-generation devices to the industry.
The primary objective for SHL Connect is to investigate the market for connectivity and emerging technologies and explore their potential application within each of SHL Group’s companies.
The necessity for autoinjector has been growing rapidly over the years, spurring a variety of innovative designs to meet patient needs and to differentiate amongst the industry.
